
Why Vendor Fragmentation Creates Risk in CDMO Operations
Why vendor fragmentation creates risk in CDMOs: challenges in sample management, storage, logistics, and chain-of-custody documentation.

Why vendor fragmentation creates risk in CDMOs: challenges in sample management, storage, logistics, and chain-of-custody documentation.

Why cell and gene therapy programs fail: transition risk, chain-of-identity gaps, and poor sample management. Learn how to build scalable CGT systems.

In regulated biorepositories, compliance requires more than documentation. Discover how governance, traceability, and CAPA systems support audit readiness.

What do auditors actually evaluate in a biorepository? Learn how governance, documentation, and traceability systems determine audit readiness.

Maintaining the integrity and security of valuable biosamples is paramount in the fast-paced world of scientific research. Unfortunately, costly mistakes can occur.

Prevent biological sample loss in GMP biostorage. Learn how redundancy, governance, and monitoring reduce risk in regulated storage.

GenVault and Diligent Pharma discuss effective CAPA use, business continuity drills, and real-world root cause analysis to enhance quality in clinical trials.

We’re excited to share that GenVault has partnered with Diligent Pharma, a company renowned for its expertise in quality and risk management in the clinical trial industry. This collaboration is a great step forward for GenVault, as it highlights our dedication to maintaining the highest standards in life sciences. After

Maintaining the integrity and security of valuable biosamples is paramount in the fast-paced world of scientific research. Unfortunately, costly mistakes can occur.

Billions of biosamples are collected each year for a plethora of studies, including research and clinical applications. One of the most pressing concerns for these samples is storage.

Billions of biosamples are collected each year for a plethora of studies, including research and clinical applications. One of the most pressing concerns for these samples is storage.

Billions of biosamples are collected each year for a plethora of studies, including research and clinical applications. One of the most pressing concerns for these samples is storage.